X and γ-rays emission probabilities of ¹³¹I and ¹³³Xe

Paşa Yalçın, Arif Baştuğ

.

DOI: 10.4236/ns.2011.37084                

Abstract

Radioactive nuclides as ¹³¹I and ¹³³Xe are increasingly used for both clinical diagnosis and therapeutic treatment of the patient. For example, ¹³¹I is used for the treatment of thyroid gland cancer. Otherwise, ¹³³Xe is used in ventilation studies to assess and evaluate pulmonary function and to provide images of the lungs in both cardiac and pulmonary diseases, such as asthma, pulmonary emphysema, bronchiectasis, carcinoma of the lung, and pulmonary embolism [1,2]. Furthermore, cerebral blood flow is measured using ¹³³Xe inhalation. In this study, the X and γ-rays emission probabilities in the decay of ¹³¹I and ¹³³Xe were precisely measured with a calibrated Si(Li) detector. Results of this study were compared using available results in the literature. Good agreement was observed between our results and available results in the literature.

Keywords

¹³¹I; ¹³³Xe; X-rays Emission Probabilities; γ-rays Emission Probabilities

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Nichols, A.L. (2001) Decay data: Review of measurements, evaluations and compilations. Applied Radiation and Isotopes, 55, 23-70. doi:10.1016/S0969-8043(00)00382-1
[2]	Birk, S., Kruuse, C., Petersen, K.A., Jonassen, O., Tfelt-Hansen, P. and Olesen, J. (2004) The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. Journal of Cerebral Blood Flow & Metabolism, 24, 1352-1358. doi:10.1097/01.WCB.0000143536.22131.D7
[3]	Miura, Y., Kanno, I., Miura, S., Hachiya, T., Hagami, E. and Uemura, K. (1981) Measurement of regional cerebral blood flow by 133Xe inhalation method-experimental system and its evaluation of data analysis by simulation study. Radioisotopes, 30, 92-98.
[4]	Monica, A.L., da Silva Maria, C.M., de Almeida Carlos, J. and da Silva Jose Delgado, U. (2004) Use of the reference source method to determine the half-lives of radionuclides of importance in nuclear medicine. Applied Radiation and Isotopes, 60, 301-305. doi:10.1016/j.apradiso.2003.11.032
[5]	Sumithrarachchi, C.S., Rengan, K. and Griffin, H.C. (2003) Measurement of absolute gamma emission probabilities. Nuclear Instruments and Methods in Physics Research Section A, 505, 343-346. doi:10.1016/S0168-9002(03)01093-3
[6]	Yal??n, P. and Kurucu, Y. (2005) Emission probabilities of K X- and g-rays following 51Cr and 67Ga decay. Applied Radiation and Isotopes, 62, 63-67. doi:10.1016/j.apradiso.2004.05.078
[7]	Yal??n, P., Sülün, A., Ba?tu?, A., Kurucu, Y., ?ahin, Y. (2005) The efficiency determination for Si(Li) detector in the 3-723 keV energy range. Canadian Journal of Analytical Sciences and Spectroscopy, 50, 108-115.
[8]	Debertin, K. and Sch?tzig, U. (1977) Limitations of the pulser method for pile-up corrections in Ge(Li) spectrometry. Nuclear Instruments and Methods in Physics Research Section A, 140, 337-344. doi:10.1016/0029-554X(77)90302-0
[9]	Debertin, K. and Sch?tzig, U. (1979) Coincidence summing corrections in Ge(Li) spectrometry at low source- -to-detector distances. Nuclear Instruments and Methods in Physics Research Section A, 158, 471-478. doi:10.1016/S0029-554X(79)94845-6
[10]	Evaluated Nuclear Structure Data File (2011) http://ie.lbl.gov/toi/nucSearch.asp
[11]	Lederer, C.M., Hollander, J.M. and Primer, I. (1967) Table of izotopes, John Wiley & Sons, New-York.
[12]	Debertin, K. and Helmer, R.G. (1988) Gamma and X-ray spectrometry with semiconductor detectors. Elsevier Sci- ence, Amsterdam.